Good binocular results in children with early-onset exotropia

Article

The surgical outcomes for children treated for constant early-onset exotropia demonstrated good binocular results, claims a study in the journal Eye.

The surgical outcomes for children treated for constant early-onset exotropia demonstrated good binocular results, claims a study in the journal Eye.

A research team led by Dr S. Y. Suh, Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea, examined the medical records of 45 exotropia patients with a reported onset before one year of age. All patients were operated on between 2008 and 2011 and clinical characteristics and surgical outcomes were analysed retrospectively.

Patients were divided into either a constant exotropia group (XT) or and intermittent group (X(T)). The team compared clinical features and surgical results of exotropia between the two groups. The mean age at surgery was 4.5±2.4 years and the mean postoperative follow-up period was 17.3 months.

Of the total patients reviewed, 67% demonstrated an alignment of less than ±10 prism diopters (PD) at the final visit. In all 34 testable patients, gross stereopsis was achieved and bifixation was developed in 10 patients. There were no significant differences between the groups with regards to surgical success rates and binocularities.

Both motor and sensory surgical outcomes were not poor in early-onset exotropia patients, even in those with constant deviation.

The abstract can be read here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.